Literature DB >> 10850859

Interleukin-1 and the immunogenetics of Alzheimer disease.

R E Mrak1, W S Griffin.   

Abstract

Established genetic causes of familial Alzheimer disease (AD) involve genes for beta-amyloid precursor protein (betaAPP), presenilin-1, and presenilin-2. For the more common sporadic forms of AD, increased risk has been associated with a number of genes; the most important of which is the epsilon4 allele of apolipoprotein E. Two recent studies, one clinical and one using postmortem material, now show increased risk for AD associated with certain polymorphisms in the genes encoding the alpha and beta isoforms of interleukin-1 (IL-1). IL-1 levels are elevated in Alzheimer brain, and overexpression of IL-1 is associated with beta-amyloid plaque progression. IL-1 interacts with the gene products of several other known or suspected genetic risk factors for AD, including betaAPP, apolipoprotein E, alpha1-antichymotrypsin, and alpha2-macroglobulin. IL-1 overexpression is also associated with environmental risk factors for AD, including normal aging and head trauma. These observations suggest an important pathogenic role for IL-1, and for IL-1-driven cascades, in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850859      PMCID: PMC3833594          DOI: 10.1093/jnen/59.6.471

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  73 in total

1.  Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo.

Authors:  J G Sheng; S G Zhu; R A Jones; W S Griffin; R E Mrak
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

2.  Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.

Authors:  W S Griffin; J G Sheng; J E McKenzie; M C Royston; S M Gentleman; R A Brumback; L C Cork; M R Del Bigio; G W Roberts; R E Mrak
Journal:  Neurobiol Aging       Date:  1998 Sep-Oct       Impact factor: 4.673

3.  Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression.

Authors:  Y Li; L Liu; J Kang; J G Sheng; S W Barger; R E Mrak; W S Griffin
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  S100beta induction of the proinflammatory cytokine interleukin-6 in neurons.

Authors:  Y Li; S W Barger; L Liu; R E Mrak; W S Griffin
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

5.  Association of interleukin-1 gene polymorphisms with Alzheimer's disease.

Authors:  J A Nicoll; R E Mrak; D I Graham; J Stewart; G Wilcock; S MacGowan; M M Esiri; L S Murray; D Dewar; S Love; T Moss; W S Griffin
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

6.  Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.

Authors:  M C Royston; J E McKenzie; S M Gentleman; J G Sheng; D M Mann; W S Griffin; R E Mrak
Journal:  Neuropathol Appl Neurobiol       Date:  1999-10       Impact factor: 8.090

7.  Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation.

Authors:  J Hu; L J Van Eldik
Journal:  Brain Res       Date:  1999-09-18       Impact factor: 3.252

8.  Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes.

Authors:  V R Lombardi; M García; R Cacabelos
Journal:  J Neurosci Res       Date:  1998-11-15       Impact factor: 4.164

9.  Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.

Authors:  L M Grimaldi; V M Casadei; C Ferri; F Veglia; F Licastro; G Annoni; I Biunno; G De Bellis; S Sorbi; C Mariani; N Canal; W S Griffin; M Franceschi
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

10.  Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.

Authors:  J G Sheng; W S Griffin; M C Royston; R E Mrak
Journal:  Neuropathol Appl Neurobiol       Date:  1998-08       Impact factor: 8.090

View more
  28 in total

1.  Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

Authors:  Y Matsuoka; M Picciano; B Malester; J LaFrancois; C Zehr; J M Daeschner; J A Olschowka; M I Fonseca; M K O'Banion; A J Tenner; C A Lemere; K Duff
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

3.  Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.

Authors:  G Esposito; C Scuderi; C Savani; L Steardo; D De Filippis; P Cottone; T Iuvone; V Cuomo; L Steardo
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

4.  Interaction between prion protein and interleukin-1A genes increases early-onset Alzheimer's disease risk.

Authors:  Onofre Combarros; Javier Llorca; Pascual Sánchez-Juan; Ignacio Mateo; Jon Infante; Eloy Rodríguez; Coro Sánchez-Quintana; José Berciano
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

5.  Glutamate excitotoxicity in the cerebellum mediated by IL-1β.

Authors:  Alma Nazlie Mohebiany; Raphael Schneider
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

6.  Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

Authors:  Omar Touzani; Herve Boutin; Rosalind LeFeuvre; Lisa Parker; Andy Miller; Giamal Luheshi; Nancy Rothwell
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

7.  Caspase-1 genetic variation is not associated with Alzheimer's disease risk.

Authors:  José Luis Vázquez-Higuera; Eloy Rodríguez-Rodríguez; Pascual Sánchez-Juan; Ignacio Mateo; Ana Pozueta; Ana Martínez-García; Ana Frank; Fernando Valdivieso; José Berciano; María J Bullido; Onofre Combarros
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

8.  Iron potentiates microglial interleukin-1β secretion induced by amyloid-β.

Authors:  Israel C Nnah; Chih-Hao Lee; Marianne Wessling-Resnick
Journal:  J Neurochem       Date:  2020-01-21       Impact factor: 5.372

9.  Vitamin E suppression of microglial activation is neuroprotective.

Authors:  Y Li; L Liu; S W Barger; R E Mrak; W S Griffin
Journal:  J Neurosci Res       Date:  2001-10-15       Impact factor: 4.164

10.  Interleukin-1β in Central Nervous System Injury and Repair.

Authors:  Nicole A Jackman; Robert J Claycomb; Sandra J Hewett
Journal:  Eur J Neurodegener Dis       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.